Raul Mostoslavsky
- Massachusetts General Hospital · Internal Medicine (investigator's affiliation)
From the FY2026 NIH awards this investigator leads as contact PI. The department is the award's.
FY2026 NIH rank #10,646
- Rising Star
- R01 Holder
- Early Career
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 8626392Search this ID in NIH RePORTER
- ORCID iD
- https://orcid.org/0000-0002-7740-5212Verified identifier for this researcher
- ScienceDex PI coverage
- FY2024 through FY2026Career claims are limited to the years shown.
NIH Funding · FY2026
Linked Award Amount
$1.9M
Full award amounts, FY2026
Award Records
2
Records listing this PI
Award-Linked Rank
#10,646
By linked amount among FY2026 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2026 award records by amount
NIH award records listing Raul Mostoslavsky as a PI. Multi-PI records show the full award amount for context.
- 4R01CA279173-03R01Contact PIA novel, glutathione-dependent metabolic pathway drives metastatic outgrowth in pancreatic cancerMassachusetts General Hospital · Internal Medicine (investigator's affiliation)$1.5Maward amount
- 5R35GM158046-02R35Contact PIRevealing the crosstalk between one carbon metabolism, SAM availability and chromatin methylationMassachusetts General Hospital · Internal Medicine (investigator's affiliation)$453.8Kaward amount
Award organization
Organizations that administered FY2026 awards listing Raul Mostoslavsky as a PI.
FY2026 award administered by Massachusetts General Hospital (MA).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardMassachusetts General Hospital
- 2025$500K Cumulative Funding
- 2025$1M Cumulative Funding
- 2025R01 Grant Holder
- 2026$2M Cumulative Funding